RHYTHM PHARMACEUTICALS, INC. — Cash Flow Charts
8 quarters of history · ending 2025-12-31 · SEC EDGAR
Source:10-K · 10-Q
Capital Allocation
How management deploys cash: investing in the business (Capex + M&A) vs returning to shareholders (Buybacks + Dividends).
Capital Allocation Waterfall
Buybacks vs Stock-Based Comp
Net Debt Issuance
Cash Flow
Cash Flow by Activity
Operating Cash Flow↑+1.0% +$392K
$-40M
Free Cash Flow
$-905K
Investing Cash Flow↑+43.4% +$9M
$30M
Financing Cash Flow↑+7496.3% +$187M
$189M
Capex
$905K
Stock-Based Comp↑+82.5% +$9M
$19M
Debt Issued
—
Debt Repaid↑+41.8% +$2M
$5M
D&A
—
SBC Allocated Expense↑+82.5% +$9M
$19M